| Not Yet Recruiting | Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphi NCT07178912 | M.D. Anderson Cancer Center | Phase 2 |
| Not Yet Recruiting | A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged NCT07283640 | M.D. Anderson Cancer Center | Phase 1 |
| Recruiting | Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma NCT06961669 | Anhui Provincial Hospital | N/A |
| Not Yet Recruiting | Role of Cbc Indices in Acute Lymphoblastic Leukemia Patients NCT06746571 | Sohag University | N/A |
| Recruiting | A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphobla NCT06207123 | University of Chicago | Phase 1 / Phase 2 |
| Not Yet Recruiting | Treatment Protocol for Newky Diagnosed Adult Ph Positive ALL NCT06175702 | PETHEMA Foundation | — |
| Recruiting | TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II NCT05848687 | Tanja Andrea Gruber | Phase 1 / Phase 2 |
| Active Not Recruiting | Study of Brexucabtagene Autoleucel Plus Dasatinib in Adults With Acute Lymphoblastic Leukemia NCT05993949 | Stanford University | Phase 1 |
| Active Not Recruiting | A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leuke NCT05885464 | Beam Therapeutics Inc. | Phase 1 / Phase 2 |
| Recruiting | Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors NCT05194397 | Children's Hospital of Philadelphia | Phase 2 |
| Unknown | Efficacy of Osteopathic Treatment on the Side Effects of Curative Treatments of Lymphoblastic Leukemia in Pedi NCT05664230 | Assistance Publique - Hôpitaux de Paris | — |
| Unknown | Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage NCT05429905 | KK Women's and Children's Hospital | Phase 1 / Phase 2 |
| Recruiting | CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lym NCT05648019 | KK Women's and Children's Hospital | Phase 2 |
| Recruiting | CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic NCT05043571 | National University Hospital, Singapore | Phase 1 |
| Recruiting | ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia. NCT05038696 | National University Hospital, Singapore | Phase 1 |
| Suspended | Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin ( NCT04747912 | University of Chicago | Phase 2 |
| Completed | An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lympho NCT04145531 | Jazz Pharmaceuticals | Phase 2 / Phase 3 |
| Completed | Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma NCT03328104 | Emory University | Phase 1 |
| Unknown | Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL NCT03564704 | Nanfang Hospital, Southern Medical University | Phase 2 / Phase 3 |
| Completed | Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute L NCT01615809 | Fundació Sant Joan de Déu | Phase 2 |
| Terminated | Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors NCT01100658 | University of Minnesota | N/A |
| Completed | Intensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic Malignancies NCT00988013 | University of Illinois at Chicago | N/A |
| Terminated | Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) NCT00967343 | Kiadis Pharma | Phase 2 / Phase 3 |
| Terminated | Rapamycin in With High-Dose Etoposide and Cytarabine in Relapsed/Refractory Aggressive Lymphoid Malignancies NCT00776373 | Abramson Cancer Center at Penn Medicine | Phase 1 / Phase 2 |
| Completed | Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia NCT00866749 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Depocyte in the Treatment of CNS Relapse in Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma NCT00388531 | PETHEMA Foundation | Phase 2 |
| Completed | Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus NCT00133367 | Massachusetts General Hospital | Phase 2 |
| Completed | Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant NCT00354120 | Gruppo Italiano Trapianto di Midollo Osseo | Phase 2 / Phase 3 |